At NIHR Bristol BRC, we collaborate with a range of health innovation partners, including pharmaceutical companies, life science innovators and charities. We are always keen to hear from new potential partners.
Specialising in early-phase translational research, we are well placed to overcome bottlenecks, moving breakthroughs along the research pipeline towards implementation.
We have particular capabilities in molecular epidemiology, children’s health and surgical, respiratory and data science.
Benefitting from our network
We work closely with the University of Bristol’s Translational Research Hub, which acts as a single point of entry for companies who want to commercialise their discoveries.
We also collaborate with SetSquared, the world’s top-ranked business incubation network and the West of England Academic Health Science Network to strengthen the local innovation pipeline.
Existing commercial partnerships
Our high-profile commercial partnerships include:
Population-based surveillance of vaccine-preventable diseases with our Pfizer Vaccine Centre of Excellence
Algorithms for early detection and treatment of exacerbations of asthma and COPD with MyMHealth
Medication adherence and self-management through digital inhalers with AstraZeneca, GlaxoSmithKline and Chiesi
A device for sensing ammonia for diagnosing and monitoring metabolic disorders with Breath DX
Fibroin silk technologies for cartilage injuries with Orthox
Ceramic articulations in hip replacement with Ceramtec
OpenGWAS/MR-Base platform hosted in Oracle Cloud
Machine learning approaches to identify prognostic indicators in Parkinson’s disease with Biogen
‘First in human’ trial of a weight management capsule with Oxford Medical Products